Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Science Enterprises (OSE), formerly known as Oxford Science Innovation (OSI), is a major independent investment company that builds and funds world-leading businesses based on scientific breakthroughs from the University of Oxford. Founded in 2015, the company focuses on three primary sectors: Life Sciences, Health Tech, and Deep Tech. OSE acts as a founding partner, providing capital, strategic guidance, and operational support to transform academic research into commercial enterprises. Its extensive portfolio includes over 100 companies, many of which are developing novel therapeutic modalities and diagnostic tools to address significant unmet medical needs. The firm plays a central role in the Oxford ecosystem, leveraging its unique partnership with the university to drive innovation in global healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Office of Science and Innovation.